Changes in Hepatic Fibrosis Stages After Achieving SVR Following Direct Acting Antiviral Treatment: A Prospective Study

GastroHep
doi 10.1002/ygh2.384
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Predictors of Hepatocellular Carcinoma After Hepatitis C Virus Eradication Following Direct-Acting Antiviral Treatment: Relationship With Serum Zinc

Journal of Clinical Biochemistry and Nutrition
MedicineNutritionClinical BiochemistryDietetics
2020English

Hepatocellular Carcinoma Risk After Direct-Acting Antiviral Therapy

Clinical Liver Disease
Hepatology
2019English

Persistent Hepatitis C Virus-Associated Cryoglobulinemic Vasculitis Following Virus Eradication After Direct-Acting Antiviral Therapy

Hepatology
MedicineHepatology
2017English

No Evidence for Higher Rates of Hepatocellular Carcinoma After Direct-Acting Antiviral Treatment: A Meta-Analysis

Hepatoma Research
2019English

Relapse or Reinfection After Failing Hepatitis C Direct Acting Antiviral Treatment: Unravelled by Phylogenetic Analysis

PLoS ONE
Multidisciplinary
2018English

Will IL28B Polymorphisms Remain Relevant to Direct-Acting Antiviral Treatment Paradigms?

Antiviral Therapy
Infectious DiseasesPharmacology
2012English

Patient-Reported Symptoms During Direct-Acting Antiviral Treatment: A Real-Life Study in HIV-HCV Coinfected Patients (ANRS CO13 HEPAVIH)

Journal of Hepatology
Hepatology
2020English

Direct-Acting Antiviral Treatment for Hepatitis C Virus Infection and Risk of Incident Liver Cancer: A Retrospective Cohort Study

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Oral Direct-Acting Antiviral Therapy for Hepatitis C

Journal of Antivirals & Antiretrovirals
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy